Indefinite Delivery Contract SPE2D219D0062

Award Date 10/18/18
Last Date to Order 10/17/23
Federal Agency
Medical Supply Chain
Ultimate Awardee
Gsms Inc.
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This single-award Indefinite Delivery Contract was awarded on January 26, 2022 by the Medical Supply Chain (alternate name for the Defense Logistics Agency) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $24,393,556.55 and an ultimate completion date of January 25, 2027. The contract is focused on the manufacture and distribution of a wide range of essential pharmaceutical...
The federal contract IDV award SPE2D223D0013 is a single-award Indefinite Delivery Contract valued at $3,988,286.45 and awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract, which does not utilize any set-asides, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) with an ultimate completion date of September 26, 2028. The contract is focused on providing a wide range...
The Defense Logistics Agency Troop Support Medical awarded an Indefinite Delivery Contract to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract, valued at up to $22,690,188.20, facilitates the delivery of various dosages and quantities of omeprazole capsules to Department of Defense and Bureau of Prisons customers through the DLA and VA prime vendor programs. The contract includes a one-year base period with...
The federal contract IDV award SPE2D221D0127 was granted to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The IDV has a ceiling value of $23,136,506.40 and was awarded on December 1, 2020 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The IDV is designed to provide an uninterrupted supply of essential pharmaceutical products, including tablets and capsules for...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract, awarded by the Medical Supply Chain division of the U.S. Department of Defense (DoD), has a ceiling value of $13,436,082.40 and an ultimate completion date of March 5, 2028. Under this IDC, Golden State Medical Supply, Inc. provides a wide range of essential...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The contract has a potential value of $2,693,678.00 and a period of performance through January 7, 2025. The contract enables Golden State Medical Supply to provide a wide range of pharmaceutical products on an as-needed basis to meet the medication requirements of the...
The key elements of this federal contract IDV award are as follows: The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $6,883,760.65 and a period of performance through November 15, 2027. This single-award IDC is not designated as a set-aside. Under this IDC, Golden State Medical Supply has received...
The provided information details an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a pharmaceutical manufacturer and distributor based in Camarillo, California. The single-award IDC has a ceiling value of $73,378,778.32 and a period of performance from April 7, 2022 to April 6, 2027. Under this IDC, Golden State Medical Supply, Inc. is tasked with providing a wide range of essential pharmaceutical products to federal...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. (a subsidiary of Gsms Inc.), a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract, valued at up to $2,733,763.50, is for the provision of Dalfampridine SA Tablets over a base year and four one-year option periods. The contract was awarded on January 29, 2020 and allows for orders to be placed...
The federal contract IDV award was issued by the VA National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The single-award, indefinite delivery contract has a ceiling value of $4,928,686.10 and a period of performance from February 13, 2023, to February 12, 2026, with the option to extend for four additional one-year periods. Under this contract, Golden State Medical Supply, Inc. will provide an...

The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceutical and medical products. The contract has a potential value of $3,651,502.35 and a period of performance from October 18, 2018 to October 17, 2023. Through this single-award IDV, Golden State Medical Supply provides a range of pharmaceutical products, including heartburn medications, diabetes drugs, antibiotics, and antivirals, to U.S. government agencies such as the Department of Veterans Affairs and Department of Defense. Task orders under the IDV leverage Golden State Medical Supply's distribution infrastructure to supply these standard medications and products to VA hospitals, DoD treatment facilities, prisons, and Indian Health Services centers as needed.

The original solicitation, planned to be issued in December 2017, was for a firm-fixed price, requirements-type contract to establish a national supply source for Quetiapine Fumarate Extended Release (XR) Tablets in various dosages for the DoD, Bureau of Prisons, Indian Health Service, and VA, to be procured through the DLA and VA prime vendor programs. This commercial item acquisition was unrestricted and fully competitive, with no set-asides used.

Generated 3/30/24, 9:06 AM